000513.SZ
丽珠集团
SZSE · Healthcare · C 制造业 · CN
CNY 26.34
−9.98%Year over year
Reported trailing growth
- Revenue
- -0.3%
- EBITDA
- —
- EBIT
- -3.8%
- EPS
- -3.9%
- Free cash flow
- +21.9%
- Operating cash flow
- +16.5%
Forward estimates
Based on analyst estimates
- Revenue
- -55.3%
- EBITDA
- -57.7%
- EPS
- -54.3%
Three-year CAGR
- Revenue
- -1.6%
- EBITDA
- +5.6%
- EBIT
- +7.8%
- Net income
- +1.9%
- EPS
- +3.6%
- Free cash flow
- +11.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026